PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.42%
Positive revenue growth while BIDU is negative. John Neff might see a notable competitive edge here.
2.86%
Positive gross profit growth while BIDU is negative. John Neff would see a clear operational edge over the competitor.
-3.37%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-3.37%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
3.77%
Net income growth under 50% of BIDU's 28.50%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.78%
EPS growth under 50% of BIDU's 30.49%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
2.86%
Diluted EPS growth under 50% of BIDU's 29.27%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.25%
Share count expansion well above BIDU's 0.08%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.23%
Diluted share count expanding well above BIDU's 0.05%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
7.95%
OCF growth of 7.95% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
4.20%
FCF growth of 4.20% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
636.59%
10Y revenue/share CAGR under 50% of BIDU's 7251.65%. Michael Burry would suspect a lasting competitive disadvantage.
117.10%
5Y revenue/share CAGR under 50% of BIDU's 339.78%. Michael Burry would suspect a significant competitive gap or product weakness.
46.28%
3Y revenue/share CAGR under 50% of BIDU's 107.10%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
765.03%
OCF/share CAGR of 765.03% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
134.26%
OCF/share CAGR of 134.26% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
87.94%
3Y OCF/share CAGR of 87.94% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
508.98%
Below 50% of BIDU's 3407.28%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
74.31%
5Y net income/share CAGR 1.25-1.5x BIDU's 65.85%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
65.35%
3Y net income/share CAGR above 1.5x BIDU's 2.67%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
721.96%
Below 50% of BIDU's 6799.13%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
129.88%
Equity/share CAGR of 129.88% while BIDU is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
56.80%
Below 50% of BIDU's 153.78%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.88%
Firm’s AR is declining while BIDU shows 7.16%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
3.67%
Similar asset growth to BIDU's 3.78%. Walter Schloss finds parallel expansions or investment rates.
4.61%
1.25-1.5x BIDU's 4.01%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-6.31%
We’re deleveraging while BIDU stands at 1.48%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
6.93%
R&D growth drastically higher vs. BIDU's 6.03%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.67%
We expand SG&A while BIDU cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.